Inherited Thrombophilia: Part 1
暂无分享,去创建一个
P. Mannucci | F. Rosendaal | J. Miletich | B. Dahlbäck | M. Chandy | R. Bertina | K. Bauer | D. Lane | U. Seligsohn | V. Boulyjenkov | E. Ginter | B. Dahlback | N. Bochkov | D. Lane | N. Bochkov | Victor Boulyjnkov
[1] P. Mannucci,et al. Inherited Thrombophilia*: Part 2 , 1996, Thrombosis and Haemostasis.
[2] P. Reitsma,et al. Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency , 1996, Thrombosis and Haemostasis.
[3] N. Dzimiri,et al. World distribution of factor V Leiden , 1996, The Lancet.
[4] J. Vandenbroucke,et al. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen , 1995, The Lancet.
[5] M. Aiach,et al. The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency. , 1995, Blood.
[6] M. Rowley,et al. Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy , 1995 .
[7] H. Hemker,et al. Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*) , 1995, The Journal of Biological Chemistry.
[8] P. Godowski,et al. Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3 , 1995, Cell.
[9] J. Sixma,et al. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. , 1995, Blood.
[10] J. Emmerich,et al. A Review of Mutations Causing Deficiencies of Antithrombin, Protein C and Protein S , 1995, Thrombosis and Haemostasis.
[11] J. Griffin,et al. Activated Protein C Resistance: Molecular Mechanisms , 1995, Thrombosis and Haemostasis.
[12] B. Dahlbäck,et al. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. , 1995, Blood.
[13] B. Dahlbäck,et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. , 1995, Blood.
[14] D. Cooper,et al. Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells. , 1995, The Biochemical journal.
[15] H. Azuma,et al. Congenital deficiency of histidine-rich glycoprotein: failure to identify abnormalities in routine laboratory assays of hemostatic function, immunologic function, and trace elements. , 1995, The Journal of laboratory and clinical medicine.
[16] P. Reitsma,et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) , 1995, Blood.
[17] P. Reitsma,et al. Identification of Eight Point Mutations in Protein S Deficiency Type I – Analysis of 15 Pedigrees , 1995, Thrombosis and Haemostasis.
[18] P. Reitsma,et al. Protein C Deficiency: A Database of Mutations, 1995 Update , 1995, Thrombosis and Haemostasis.
[19] H. Blom,et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? , 1995, The Lancet.
[20] P. Ridker,et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.
[21] S. Thein,et al. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site , 1995 .
[22] P. Reitsma,et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.
[23] K. Mann,et al. Characterization of the Molecular Defect in Factor VR506A(*) , 1995, The Journal of Biological Chemistry.
[24] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[25] R. Marlar,et al. THE FIRST MUTATION IDENTIFIED IN THE THROMBOMODULIN GENE IN A 45-YEAR-OLD MAN PRESENTING WITH THROMBOEMBOLIC DISEASE , 1995 .
[26] K. Mann,et al. The mechanism of inactivation of human factor V and human factor Va by activated protein C. , 1994, The Journal of biological chemistry.
[27] P. Reitsma,et al. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families. , 1994, Blood.
[28] J. Griffin,et al. Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V , 1994 .
[29] W. Lissens,et al. Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation. , 1994, Blood.
[30] M. Malinow. Homocyst(e)ine and arterial occlusive diseases , 1994, Journal of internal medicine.
[31] A. Girolami,et al. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[32] P. Reitsma,et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation , 1994, The Lancet.
[33] T. Barrowcliffe,et al. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide. , 1994, The Journal of biological chemistry.
[34] S. Thein,et al. A polymorphism in the human coagulation factor V gene. , 1994, Human molecular genetics.
[35] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.
[36] M. Aiach,et al. First frameshift mutation in the active protein S gene associated with a quantitative hereditary deficiency. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[37] B. Dahlbäck,et al. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. , 1994, The Journal of biological chemistry.
[38] P. Mannucci,et al. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[39] J. Voorberg,et al. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V , 1994, The Lancet.
[40] B. Dahlbäck,et al. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis , 1994, The Lancet.
[41] P. Reitsma,et al. Homzygous Protein S Deficiency due to a One Base Pair Deletion that Leads to a Stop Codon in Exon III of the Protein S Gene , 1994, Thrombosis and Haemostasis.
[42] J. Vandenbroucke,et al. John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study , 1994, British journal of haematology.
[43] B. Evatt,et al. Activated protein C resistance caused by Arg506Gln mutation in factor Va , 1994, The Lancet.
[44] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[45] B. Lämmle,et al. Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication , 1994, Thrombosis and Haemostasis.
[46] J. Griffin,et al. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three‐dimensional molecular modelling of mutations of the protease domain , 1994, Proteins.
[47] José A Fernández,et al. Protein S binds to and inhibits factor Xa. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] B. Dahlbäck,et al. Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.
[49] P. Reitsma,et al. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. , 1994, The Journal of clinical investigation.
[50] Tatsuya Hayashi,et al. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. , 1994, Blood.
[51] E. Sacchi,et al. Resistance to Activated Protein C in Nine Thrombophilic Families: Interference in a Protein S Functional Assay , 1993, Thrombosis and Haemostasis.
[52] F. Rosendaal,et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.
[53] J. Griffin,et al. Anticoagulant protein C pathway defective in majority of thrombophilic patients. , 1993, Blood.
[54] F. Bernardi,et al. Study of a protein S gene polymorphism at DNA and mRNA level in a family with symptomatic protein S deficiency , 1993, British journal of haematology.
[55] D. Cooper,et al. Antithrombin III Mutation Database: First Update , 1993, Thrombosis and Haemostasis.
[56] R. Tait,et al. Protein C Activity in Healthy Volunteers - Influence of Age, Sex, Smoking and Oral Contraceptives , 1993, Thrombosis and Haemostasis.
[57] I. Walker,et al. Influence of demographic factors on antithrombin III activity in a healthy population , 1993, British journal of haematology.
[58] C. Esmon. Molecular Events that Control the Protein C Anticoagulant Pathway , 1993, Thrombosis and Haemostasis.
[59] A. Wacey,et al. A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency , 1993, British journal of haematology.
[60] G. Leone,et al. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. , 1993, Biochemistry.
[61] J. Griffin,et al. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. , 1993, The Journal of biological chemistry.
[62] F. Rodeghiero,et al. High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families. , 1993, Thrombosis research.
[63] P. Bird,et al. Effects of annexin V on the activity of the anticoagulant proteins C and S. , 1993, Thrombosis research.
[64] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[65] P. Reitsma,et al. Citations from the Literature , 2003 .
[66] P. Reitsma,et al. Protein C Deficiency: A Database of Mutations , 1993, Thrombosis and Haemostasis.
[67] M. Hultin,et al. Pleiotropic effects of antithrombin strand 1C substitution mutations. , 1992, The Journal of clinical investigation.
[68] M. Blajchman,et al. Molecular basis of inherited human antithrombin deficiency , 1992 .
[69] W. Halbmayer,et al. The Prevalence of Factor XII Deficiency in 103 Orally Anticoagulated Outpatients Suffering from Recurrent Venous and/or Arterial Thromboembolism , 1992, Thrombosis and Haemostasis.
[70] R. Bertina,et al. β2-Glycoprotein I Deficiency and the Risk of Thrombosis , 1992, Thrombosis and Haemostasis.
[71] L. Cripe,et al. Structure of the gene for human coagulation factor V. , 1992, Biochemistry.
[72] C. Esmon. The protein C anticoagulant pathway. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[73] D. Perry,et al. Antithrombin III: A Database of Mutations , 1991, Thrombosis and Haemostasis.
[74] P. Reitsma,et al. A CCA/CCG neutral dimorphism in the codon for Pro 626 of the human protein S gene PSα (PROS1) , 1991 .
[75] F. Rosendaal,et al. Mortality related to thrombosis in congenital antithrombin III deficiency , 1991, The Lancet.
[76] G. Leone,et al. Mortality related to thrombosis in congenital antithrombin III deficiency , 1991, The Lancet.
[77] A. Órfão,et al. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis , 1991, American journal of hematology.
[78] D. Hommes,et al. Mortality in hereditary antithrombin-III deficiency—1830 to 1989 , 1991, The Lancet.
[79] R. Marlar,et al. A 5.3-kb deletion including exon XIII of the protein S alpha gene occurs in two protein S-deficient families. , 1991, Blood.
[80] H. Büller,et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.
[81] G. Long,et al. Organization of the human protein S genes. , 1990, Biochemistry.
[82] J. Stenflo,et al. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. , 1990, Biochemistry.
[83] Bertina Rm,et al. Intron-exon organization of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. , 1990 .
[84] P. Reitsma,et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. , 1990, Blood.
[85] M. Samama,et al. Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women , 1990, Thrombosis and Haemostasis.
[86] P. Reitsma,et al. A Mutation in the Protein S Pseudogene Is Linked to Protein S Deficiency in a Thrombophilic Family , 1989, Thrombosis and Haemostasis.
[87] D. Lane,et al. Antithrombin: structure, genomic organization, function and inherited deficiency. , 1989, Bailliere's clinical haematology.
[88] J. Hirsh,et al. Congenital antithrombin III deficiency. Incidence and clinical features. , 1989, The American journal of medicine.
[89] U. Abildgaard,et al. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate. , 1989, The Journal of biological chemistry.
[90] A. Zivelin,et al. The Relative Frequency of Hereditary Thrombotic Disorders Among 107 Patients with Thrombophilia in Israel , 1989, Thrombosis and Haemostasis.
[91] P. Callas,et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. , 1989, Blood.
[92] P. Reitsma,et al. Partial protein S gene deletion in a family with hereditary thrombophilia , 1989 .
[93] P. Reitsma,et al. Two RFLPS ˜ 7kb 5′ of the human protein C gene , 1988 .
[94] J. Marrinan,et al. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site. , 1988, Biochemistry.
[95] J. Soria,et al. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. , 1988, The Journal of clinical investigation.
[96] J. Griffin,et al. The Frequency of Type I Heterozygous Protein S and Protein C Deficiency in 141 Unrelated Young Patients with Venous Thrombosis , 1988, Thrombosis and Haemostasis.
[97] T. Barbui,et al. Different Prevalence of Thromboembolism in the Subtypes of Congenital Antithrombin III Deficiency:Review of 404 Cases , 1987, Thrombosis and Haemostasis.
[98] C. Kluft,et al. Familial elevation of plasma histidine‐rich glycoprotein in a family with thrombophilia , 1987, British journal of haematology.
[99] J. Miletich,et al. Absence of thrombosis in subjects with heterozygous protein C deficiency. , 1987, The New England journal of medicine.
[100] E. Davie,et al. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. , 1987, Biochemistry.
[101] P. Reitsma,et al. Human protein S cDNA encodes Phe‐16 and Tyr 222 in consensus sequences for the post‐translational processing , 1987, FEBS letters.
[102] K. Mann,et al. Complete cDNA and derived amino acid sequence of human factor V. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[103] R. Bertina,et al. Hereditary Heparin Cofactor II Deficiency and the Risk of Development of Thrombosis , 1987, Thrombosis and Haemostasis.
[104] W. Kane,et al. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[105] G. Crabtree,et al. Evolution and organization of the human protein C gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[106] B. Boneu,et al. CONSTITUTIONAL HEPARIN CO-FACTOR II DEFICIENCY ASSOCIATED WITH RECURRENT THROMBOSIS , 1985, The Lancet.
[107] G. Crabtree,et al. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. , 1985, Nucleic acids research.
[108] E. Davie,et al. The nucleotide sequence of the gene for human protein C. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[109] E. Briët,et al. Hereditary Protein S Deficiency and Venous Thrombo-Embolism , 1985, Thrombosis and Haemostasis.
[110] J. Griffin,et al. Plasma protein S deficiency in familial thrombotic disease. , 1984, Blood.
[111] E. Davie,et al. Characterization of a cDNA coding for human protein C. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[112] E. Prochownik,et al. Isolation of a cDNA clone for human antithrombin III. , 1983, The Journal of biological chemistry.
[113] M. Skolnick,et al. Familial Antithrombin III Deficiency: Its Natural History, Genetics, Diagnosis and Treatment , 1983, Medicine.
[114] V. Kidd,et al. Isolation and sequence characterization of a cDNA clone of human antithrombin III. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[115] R. Lawn,et al. Cloning and expression of the cDNA for human antithrom, bin III , 1982 .
[116] J. Griffin,et al. Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.
[117] K. Lechner,et al. Antithrombin III deficiency and thromboembolism. , 1981, Clinics in haematology.
[118] M. Hoylaerts,et al. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. , 1980, The Journal of biological chemistry.
[119] O. Egeberg. Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.
[120] P. Reitsma,et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. , 1996, The New England journal of medicine.
[121] B. Dahlbäck. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. , 1995, Thrombosis research.
[122] B. Jude,et al. Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. , 1995, Blood.
[123] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[124] M. Samama,et al. Familial Dysfibrinogenemia and Thrombophilia , 1995, Thrombosis and Haemostasis.
[125] P. Reitsma,et al. Prevalence of Protein C Deficiency in the Healthy Population , 1995, Thrombosis and Haemostasis.
[126] D. Cooper,et al. Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. , 1995, Blood.
[127] R. Marlar,et al. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. , 1995, Blood.
[128] S. Thein,et al. Antithrombin: The Principal Inhibitor of Thrombin , 1994, Seminars in thrombosis and hemostasis.
[129] S. Thein,et al. (ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations , 1994, Human mutation.
[130] R. Vervoort,et al. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. , 1994, Blood.
[131] D. Cooper,et al. Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single‐strand conformation polymorphism analysis , 1993, Human mutation.
[132] P. Reitsma,et al. A CCA/CCG neutral dimorphism in the codon for Pro 626 of the human protein S gene PS alpha (PROS1). , 1991, Nucleic acids research.
[133] P. Comp. Laboratory evaluation of protein S status. , 1990, Seminars in thrombosis and hemostasis.
[134] P. Reitsma,et al. Intron-exon organization of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. , 1990, Biochemistry.
[135] P. Reitsma,et al. Partial protein S gene deletion in a family with hereditary thrombophilia. , 1989, Blood.
[136] E. H. Cohen,et al. The gene for protein S maps near the centromere of human chromosome 3. , 1988, Blood.
[137] P. Reitsma,et al. Two RFLPS approximately 7 kb 5' of the human protein C gene. , 1988, Nucleic acids research.
[138] G. Long,et al. Cloning and characterization of human liver cDNA encoding a protein S precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[139] E. Briët,et al. THROMBOPHILIA:ITS CAUSES AND A ROUGH ESTIMATE OF ITS PREVALENCE , 1987, Thrombosis and Haemostasis.
[140] V. Hach-Wunderle,et al. INCIDENCE OF DEFECTIVE T-PA RELEASE IN 158 UNRELATED YOUNG PATIENTS WITH VENOUS THROMBOSIS IN COMPARISON TO PC-, PS-, AT III-, FIBRINOGEN- AND PLASMINOGENDEFICIENCY , 1987, Thrombosis and Haemostasis.
[141] I. Balazs,et al. Assignment of the human antithrombin III structural gene to chromosome 1q23-25. , 1985, Cytogenetics and cell genetics.
[142] R. Lawn,et al. Cloning and expression of the cDNA for human antithrombin III. , 1982, Nucleic acids research.